Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Robertson

Showing results (651-660 of 683) with videos related to

Pageof 69
Sort By:
Journal of Medicinal Chemistry|February 17, 2022
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial PathogensZhenkun Ma, Shijie He, Ying Yuan, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2023
Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis modelMichelle E Ramey, Firat Kaya, Allison A Bauman, et al.
Neurosurgery|August 17, 2002
The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustineRobert G Selker, William R Shapiro, Peter Burger, et al.
The American Journal of Cardiology|December 31, 1997
Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registryT Robertson, E D Kennard, S Mehta, et al.
The New England Journal of Medicine|December 4, 1980
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgeryM D Walker, S B Green, D P Byar, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse ModelGregory T Robertson, Victoria A Ektnitphong, Michael S Scherman, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2023
Lung microenvironments harbor <i>Mycobacterium tuberculosis</i> phenotypes with distinct treatment responsesNicholas D Walter, Jackie P Ernest, Christian Dide-Agossou, et al.
ACS Infectious Diseases|September 21, 2021
Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against TuberculosisMercedes Gonzalez-Juarrero, Pradeep B Lukka, Santosh Wagh, et al.
Cancer Treatment Reports|February 1, 1983
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant gliomaS B Green, D P Byar, M D Walker, et al.
Cardiology Research and Practice|June 2, 2011
The registry and follow-up of complex pediatric therapies program of Western Canada: a mechanism for service, audit, and research after life-saving therapies for young childrenCharlene M T Robertson, Reg S Sauve, Ari R Joffe, et al.
Pageof 69

Showing results (651-660 of 683) with videos related to

Sort By:
Pageof 69
Journal of Medicinal Chemistry|February 17, 2022
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial PathogensZhenkun Ma, Shijie He, Ying Yuan, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2023
Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis modelMichelle E Ramey, Firat Kaya, Allison A Bauman, et al.
Neurosurgery|August 17, 2002
The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustineRobert G Selker, William R Shapiro, Peter Burger, et al.
The American Journal of Cardiology|December 31, 1997
Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registryT Robertson, E D Kennard, S Mehta, et al.
The New England Journal of Medicine|December 4, 1980
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgeryM D Walker, S B Green, D P Byar, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse ModelGregory T Robertson, Victoria A Ektnitphong, Michael S Scherman, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2023
Lung microenvironments harbor <i>Mycobacterium tuberculosis</i> phenotypes with distinct treatment responsesNicholas D Walter, Jackie P Ernest, Christian Dide-Agossou, et al.
ACS Infectious Diseases|September 21, 2021
Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against TuberculosisMercedes Gonzalez-Juarrero, Pradeep B Lukka, Santosh Wagh, et al.
Cancer Treatment Reports|February 1, 1983
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant gliomaS B Green, D P Byar, M D Walker, et al.
Cardiology Research and Practice|June 2, 2011
The registry and follow-up of complex pediatric therapies program of Western Canada: a mechanism for service, audit, and research after life-saving therapies for young childrenCharlene M T Robertson, Reg S Sauve, Ari R Joffe, et al.
Pageof 69